MOH — authorised 12 January 1972
- Marketing authorisation holder: ALLERGAN
- Status: likely_approved
MOH authorised Fml on 12 January 1972
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 12 January 1972.
ALLERGAN holds the Israeli marketing authorisation.